Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Centers for Disease Control and Prevention | FED |
Not provided
Not provided
Not provided
Not provided
Overdose deaths are currently the largest cause of accidental death in the US and opioid-related overdose deaths constitute the overwhelming majority of these deaths. Demands for a knowledge-base for effective law enforcement interventions is growing. This proposed study is designed to provide a knowledge base regarding key obstacles and facilitators of the willingness and preparedness of police to administer naloxone and related risk reduction practices and evaluate the efficacy of a web-based opioid-related occupational safety and risk reduction curriculum. Findings from this study will be applied to the development and implementation of effective interventions for police officers aimed at harmonizing law enforcement practices with public health goals.
This application proposes to contribute to the harmonization of law enforcement practices and public health goals to combat rising morbidity and mortality rates associated with opioid-related overdose (OD). Police departments around the U.S. are increasingly making the OD reversal drug, naloxone, available to their officers. This intervention has the potential to greatly improve emergency response after an OD. The proportion of precincts mandating that officers carry naloxone remains small, however, and barriers remain that make adoption of these first-responder programs problematic. Lawsuits from police unions contesting naloxone- related mandates and occupational safety concerns, including the potential for needle stick injuries (HIV/HCV risk) and incidental contact with fentanyl-class substances, constitute barriers, as do stigma and concerns about legal jeopardy. The study team proposes to equip police with best-practices for minimizing workplace harms related to encounters with PWUO/PWID and the legal and practical knowledge to respond confidently to an OD without fear of legal jeopardy as well as reduce health risks to PWUOs and PWIDs associated with law enforcement. More than 10,000 law enforcement officers in Pennsylvania (roughly one third of all PA officers) have already received naloxone and OD response training from GetNaloxoneNow.org (GNN), a web-based intervention. With the support of county departments of health, harm reduction agencies, law enforcement, and district attorneys, the team proposes to adapt extant interventions for police to create an online training module aimed at reducing barriers to police engagement in OD response. Using a mixed-method design, organized around a pragmatic trial design, the study will achieve the following objectives:1) Adapt an occupational risk reduction (ORR) curriculum to add to a web-based OD response and naloxone training platform (GNN); 2) Describe naloxone use patterns, OD response experiences, and attitudes related to illicit opioid use among a sample (N = 300) of police officers in PA trained via the GNN platform; 3) Evaluate the relative effectiveness of ORR + GNN, compared with GNN-only, with respect to the following outcomes: a) rates of carrying naloxone while on/off-duty; b) rates of OD response in which naloxone is/isn't administered; c) numbers of referrals to treatment; d) numbers of syringes confiscated; and e) rates of information sharing with OD survivors and others. Mediators and moderators of efficacy will also be analyzed. 4) Document the range of psychosocial mechanisms underlying participant OD response engagement post-intervention. This study aims to remove barriers to life-saving police engagement with PWUO/PWID by focusing both on the safety of law enforcement and evidence-based and best-practices for working with persons at risk of an opioid OD. The study also will provide empirical evaluation of the diffusion of naloxone-based response among law enforcement.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Opioids and Police Safety Occupational Risk Reduction Training | Experimental | Provides occupational risk reduction training for police in 49 slides including 8 filmed videos (police officers, MDs, SSP staff, a person in recovery). The training is delivered online with secure access only for enrolled study participants. |
|
| COVID Occupational Risk Reduction Training | Active Comparator | The COVID-19 and Police Safety training (Control only) includes 22 slides, also narrated by a professional voice narrator. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Opioids and Police Safety Occupational Risk Reduction Training (OPS) | Behavioral | Potential participants are provided with a flyer with directions to enroll online. Groups are randomized by zip code (all participants with the same zip code receive the same training to avoid contamination by precinct) Both the experimental and control groups first take the online GetNaloxoneNow.org First Responder training; then the experimental group takes the online OPS training and the control group takes the online COVID training. Both groups take a pre-survey prior to both trainings and a post-survey after they complete both trainings. Both groups also receive (via email) a resource list with information that was provided in their respective trainings plus additional resources re: occupational risk reduction appropriate to each training. Every quarter for one year, participants are emailed a reminder to get back online to take the survey again. |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Naloxone Behavioral Outcomes in Policing Procedure | Number of days during the past 30 days in which participants had naloxone available and carried naloxone while at work. | Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Change in Naloxone Behavioral Outcomes in Policing Procedure | Number of days during the past 30 days in which participants had naloxone available and carried naloxone outside of work hours. | Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Change in Naloxone Behavioral Outcomes in Policing Procedure | Number of days during the past 30 days in which participants responded to an OD event, attempted to intervene, and/or administered naloxone. | Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Change in Referral Behavioral Outcomes in Policing Procedure | Number of referrals to evidence-based or other drug treatment or social services made during the past 30 days. | Time frame: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Change in Confiscation Behavioral Outcomes in Policing Procedure | Number of episodes involving syringe confiscation in the past 30 days (with/without proper technique). | Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Measure | Description | Time Frame |
|---|---|---|
| Change in participant knowledge about needle stick injury and treatment | Which of the following diseases is MOST likely to be transmitted by a needle stick injury? | [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Change in participant knowledge about needle stick injury and treatment |
| Measure | Description | Time Frame |
|---|---|---|
| Degree of participant familiarity with fentanyl-class substances |
|
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| New York University | New York | New York | 10010 | United States |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 35212639 | Derived | Simmons J, Elliott L, Bennett AS, Beletsky L, Rajan S, Anders B, Dastparvardeh N. Evaluation of an Experimental Web-based Educational Module on Opioid-related Occupational Safety Among Police Officers: Protocol for a Randomized Pragmatic Trial to Minimize Barriers to Overdose Response. JMIR Res Protoc. 2022 Feb 25;11(2):e33451. doi: 10.2196/33451. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| ICF | No | No | Yes | Informed Consent Form | Jun 17, 2021 | Jun 18, 2021 | ICF_000.pdf |
Not provided
| ID | Term |
|---|---|
| D000083682 | Opiate Overdose |
| ID | Term |
|---|---|
| D062787 | Drug Overdose |
| D063487 | Prescription Drug Misuse |
| D000076064 | Drug Misuse |
| D019966 | Substance-Related Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D000701 | Analgesics, Opioid |
| ID | Term |
|---|---|
| D009294 | Narcotics |
| D002492 | Central Nervous System Depressants |
| D045505 | Physiological Effects of Drugs |
| D020228 | Pharmacologic Actions |
Not provided
Not provided
The Opioids and Police Safety Study employed a pragmatic trial design evaluated in a simultaneous embedded mixed-method approach.
Not provided
Not provided
Participants are randomized to the experimental or the control arm for occupational risk reduction trainings. Trainings are not designated as experimental or control.
CHANGE TO PROTOCOL: Control dropped to enable recruitment. Outcome measures are the same.
Not provided
|
|
| Opioids and Police Safety Occupational Risk Reduction Training (COVID) | Behavioral | Potential participants are provided with a flyer with directions to enroll online. Groups are randomized by zip code (all participants with the same zip code receive the same training to avoid contamination by precinct) Both the experimental and control groups first take the online GetNaloxoneNow.org First Responder training; then the experimental group takes the online OPS training and the control group takes the online COVID training. Both groups take a pre-survey prior to both trainings and a post-survey after they complete both trainings. Both groups also receive (via email) a resource list with information that was provided in their respective trainings plus additional resources re: occupational risk reduction appropriate to each training. Every quarter for one year, participants are emailed a reminder to get back online to take the survey again. |
|
|
| Change in Confiscation Behavioral Outcomes in Policing Procedure | Number of episodes in the past 30 days involving drug confiscation (with/without proper technique). | Time frame for all above items: the past 30 days at the time the survey is being administered; [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
The risk of getting a bloodborne infection as a result of a needle stick injury is high (check only one response). |
| [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Change in participant knowledge about needle stick injury and treatment | To avoid being stuck with a needle, police officers should (select ALL that apply) | [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Change in participant knowledge about needle stick injury and treatment | The evidentiary value of syringes and any drug residue therein is (fill in the blank by checking only one response). 5) Possession of syringes is (fill in the blank by checking only one response). 6) Confiscating syringes from people who inject drugs... (check all that apply): 7) Testing and precautionary treatment of any NSI is important, because... (fill in the blank by checking only one response). | [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Change in participant knowledge about needle stick injury and treatment | Possession of syringes is (fill in the blank by checking only one response). 6) Confiscating syringes from people who inject drugs... (check all that apply): 7) Testing and precautionary treatment of any NSI is important, because... (fill in the blank by checking only one response). | [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Change in participant knowledge about needle stick injury and treatment | Confiscating syringes from people who inject drugs... (check all that apply): 7) Testing and precautionary treatment of any NSI is important, because... (fill in the blank by checking only one response). | [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Change in participant knowledge about needle stick injury and treatment | Testing and precautionary treatment of any NSI is important, because... (fill in the blank by checking only one response). | [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Degree of participant familiarity with proper technique for dealing with contaminated injection equipment | Please indicate your agreement with the following statements relating to needle stick prevention and response (1 = strongly agree, 2 = agree, 3 = neither agree nor disagree, 4 = disagree, 5 = strongly disagree):
| [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Degree of participant awareness of post-exposure prophylaxis (PEP) and its uses | (1 = strongly agree, 2 = agree, 3 = neither agree nor disagree, 4 = disagree, 5 = strongly disagree):
| [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Degree of participant awareness of risk of fentanyl exposure and proper technique for dealing with synthetic opioids | Response options: (1 = all the time, 2 = most of the time, 3 = sometimes, 4 = rarely, 5 = never):
| [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Degree of participant familiarity with best-practices related to policing PWUO and PWID who may be carrying heroin contaminated with fentanyl-class substances |
| [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Opioid-Related OD knowledge | The items related to a participant's ability to recognize and respond to an opioid-related overdose, with or without naloxone, were adapted from the Opioid Overdose Knowledge Scale (OOKS).
| [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Hypothesized Mediators of Intervention Efficacy: Stigma | Response options: 1 = strongly agree, 2 = agree, 3 = neither agree nor disagree, 4 = disagree, 5 = strongly disagree Providing naloxone to people with addiction enables more risky drug use Distributing naloxone widely in the community is a good way to reduce overdose fatalities Rapidly giving a lot of naloxone (blasting) when reversing an overdose is a good way to teach someone a lesson It is important to prevent overdose risk directly following a period of incarceration I worry about my safety when I encounter people with addiction People with addiction make communities less safe People with addiction can make positive health choices to protect themselves or others When people with addiction are placed in secure /mandated treatment facilities, communities are better off A lot of people with addiction are outsiders coming into communities to peddle drugs | [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Potential Moderators: Demographic Variables |
| Baseline |
| Potential Moderators: Perceived Attitudes/Expectations | Response options: 1 = strongly agree, 2 = agree, 3 = neither agree nor disagree, 4 = disagree, 5 = strongly disagree
| [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Prior instances of witnessing an opioid-related overdose | The following questions relate to your experiences with opioid overdose. For each item, please choose what best describes your response to each statement (select ONLY one for each item).
| [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Prior instances of working with syringes | The following questions cover your experiences with syringes in the line of duty. Select the one best response for each item:
| [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Prior instances responding to an overdose | Now please tell us just about the following events which you may have experienced when responding to an overdose in the past 3 months.
| [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| Experiences with other programs | This next set of questions relate to your experiences with other programs in addressing the overdose crisis in your community:
| [Data collected: Baseline, Post Intervention: 90 days, 180 days, 270 days, 360 days] |
| D064419 |
| Chemically-Induced Disorders |
| D009293 | Opioid-Related Disorders |
| D000079524 | Narcotic-Related Disorders |
| D001523 | Mental Disorders |
| D020164 | Chemical Actions and Uses |
| D000700 | Analgesics |
| D018689 | Sensory System Agents |
| D018373 | Peripheral Nervous System Agents |
| D002491 | Central Nervous System Agents |
| D045506 | Therapeutic Uses |